Sitagliptin phosphate monohydrate NEW

Introduction to Sitagliptin Phosphate Monohydrate

Definition:
Sitagliptin Phosphate Monohydrate is the monohydrate form of Sitagliptin Phosphate, a selective inhibitor of the enzyme dipeptidyl peptidase-4 (DPP-4). It is commonly used in the treatment of type 2 diabetes mellitus.

Functions:

· DPP-4 Inhibition: Sitagliptin works by inhibiting DPP-4, an enzyme that breaks down incretin hormones, thus enhancing the body's ability to regulate blood sugar levels.

· Blood Sugar Control: It helps increase insulin release in response to meals and decreases glucose production by the liver, improving overall glycemic control.

· Safe and Well-Tolerated: It has a favorable safety profile with minimal risk of hypoglycemia (low blood sugar).

Applications:

· Type 2 Diabetes Treatment: Primarily used to manage blood glucose levels in patients with type 2 diabetes, either alone or in combination with other antidiabetic medications.

· Oral Medication: Available as an oral tablet, it provides a convenient and effective option for long-term management of diabetes.

· Metabolic Disorder Management: Can also be used in patients with metabolic disorders that require glucose regulation.